What Neoscan Solutions does

Neoscan Solutions GmbH is a German medical technology company founded in 2017 and headquartered in Magdeburg, Saxony-Anhalt. The company develops MRI systems and components based on proprietary high-temperature superconductor (HTS) magnet technology, which enables cryogen-free (no liquid helium), compact, and lightweight magnets compared with conventional low-temperature superconductor designs. Its flagship clinical product is the neo315, a 1.5 Tesla point-of-care MRI system with a 30 cm bore, designed specifically for newborns and infants up to six years of age, allowing installation directly in NICUs and pediatric wards without requiring a shielded RF cabin.

Neoscan's technology portfolio also includes HTS magnets for research applications (low-field up to ultra-high-field 14 Tesla), a digital RF console with software-generated Larmor frequency, the MR# sequence definition language, and the LUMINA MRI software platform. Revenue is generated primarily through hardware sales across three streams: clinical neo315 systems sold to children's hospitals and university medical centers; research-grade MRI magnets, consoles, and software sold to academic institutions; and project-based contracts such as the EUR 19 million DYNAMIC consortium agreement to build the world's first 14 Tesla human whole-body MRI magnet for Radboud University Nijmegen. The go-to-market combines direct enterprise field sales, an international distributor network (UK representative Andrew Lonergan, Arab Health channel outreach), and active participation at conferences including RSNA, Arab Health, GNPI, and GPR.

The company operates from a single facility in Magdeburg co-located with the Otto-von-Guericke University and the STIMULATE research campus. Neoscan has achieved CE certification under the EU MDR (August 2023), CB certification (March 2023), FDA 510(k) clearance (August 2024), and ISO 13485 certification. Headcount has grown from 36 employees in mid-2024 to approximately 50 employees by mid-2026. The company is privately held, founded by Stefan Röll with initial investment from Karl Gerhold (GETEC Group) and Klemens Gutman (regiocom), and supported by public grants from the state of Saxony-Anhalt, BMBF, EU, and the Netherlands Research Council. The first commercial clinical installation of neo315 occurred at University Hospital Halle in March 2025.

Name

Neoscan Solutions

Legal name

Neoscan Solutions GmbH

Website

https://neoscan-solutions.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

11–50 employees

Short description

Neoscan Solutions GmbH develops MRI systems based on proprietary high-temperature superconductor magnet technology, selling the neo315 point-of-care pediatric MRI for neonatal and infant imaging, plus HTS magnets and MRI software to hospitals and research institutions worldwide.

Ownership category

akta.pro rank

Product category

Medical Imaging Equipment

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Magnetic Resonance Imaging (MRI) Systems (HLAHABAC)

akta.pro secondary industry

Portable, Mobile & Point-of-Care Imaging Systems (HLAHABAL)

Keywords

• Pediatric MRI systems
• HTS magnet technology
• Medical imaging equipment
• MRI research equipment
• Magnetic resonance imaging

Headquarters

HQ city

Magdeburg

HQ country

Germany

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

1. MRI System Sales (neo315): Sale of the neo315 pediatric point-of-care MRI system — a 1.5 Tesla, 30cm bore system with local RF shielding. The system is sold directly to children's hospitals and university medical centers for installation in NICU and pediatric wards. CE certified (Europe) and FDA 510(k) cleared (U.S.). Pricing not publicly disclosed; involves significant enterprise sales cycles with clinical introduction support.
2. Research MRI Equipment & Components: Sale of preclinical MRI solutions and components including HTS magnets, digital consoles, and MRI software (MR#, LUMINA). Systems tailored for research or clinical settings. Also includes subsystems for integration into existing MRI setups. Sold to research institutions and academic partners.
3. 14T MRI Magnet Development (DYNAMIC Project): Neoscan was contracted to build the world's first 14 Tesla MRI magnet for the DYNAMIC consortium led by Radboud University Nijmegen, funded by Netherlands Research Council (NWO) at 19 million euros. This is a project-based revenue stream for a flagship HTS magnet.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels6 records

Core offering

Neoscan Solutions develops and manufactures MRI systems based on proprietary High-Temperature Superconductor (HTS) magnet technology. Its flagship product is the neo315, a CE-certified, cryogen-free MRI scanner built for point-of-care pediatric and neonatal use. The company also supplies research-grade HTS magnets, a digital MRI console, and proprietary software tools (MR# sequence language and LUMINA) to hospitals, university medical centers, and research institutions.

Product overview

Neoscan Solutions offers a portfolio of MRI products centered on its proprietary HTS (high-temperature superconductor) magnet technology. The flagship clinical product is the neo315, the world's first 1.5T point-of-care pediatric MRI system designed for neonates and infants. The research portfolio includes HTS magnets, a digital console with broadband RF capabilities, and two software products: MR# (a pulse sequence definition language) and LUMINA (an MR imaging and applications interface). The HTS technology enables compact, cryogen-free magnets that are repairable and reconfigurable. The company also develops ultra-high-field magnets (14T) for research applications.

Differentiator

Problem solved

Functional benefit

Brands

• neo315: Point-of-care pediatric MRI system - the first 1.5 Tesla MRI specifically designed for newborns and infants up to six years of age.
• MR#
• LUMINA SW

Products and services

• neo315 MRI System Compact, cryogen-free, point-of-care MRI system for neonatal and pediatric intensive care, designed to image children and neonates at the bedside without transport or sedation and without using ionizing radiation. CE-certified under the European Medical Device Regulation for clinical pediatric use. Sold to children's hospitals, university medical centers, and pediatric radiology departments.
• HTS MRI Magnets Research-grade High-Temperature Superconductor MRI magnets, including a 14T system under development, sold to academic and research customers for advanced MRI research. The magnets form the magnetic core of Neoscan's MRI platform.
• Digital Console Neoscan's digital MRI console is the computing and control platform for the company's MRI systems. It is CE-marked as software-as-a-medical-device and integrates with the MR# sequence definition language and LUMINA software to operate Neoscan's MRI hardware.
• MR# Pulse-Sequence Definition Language Neoscan's proprietary MR# language defines MRI pulse sequences and supports interactive experimentation in the MRI environment. It is CE-marked as software-as-a-medical-device and is used by research institutions as part of the Neoscan MRI workstation.
• LUMINA Software LUMINA is Neoscan's MRI control software, CE-marked as software-as-a-medical-device, which calculates the Larmor frequency on demand and steers the magnetic field of Neoscan MRI systems. It forms part of the delivered MRI workstation for both clinical and research users.

Quantifiable outcome

• neo315 received CE certification (August 2023) for diagnostic use in Europe and FDA 510(k) clearance (August 2024) for the U.S. market.
• +3 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Four partnerships are on record, tiered core and flagship.

• University Hospital HallecoreStrategic or Co-development Partner · 1 March 2025First clinical installation of neo315 at University Hospital Halle, inaugurated March 2025 with Saxony-Anhalt Minister of Science Armin Willingmann. The project was initiated by the University Clinic for Radiology in collaboration with the Department of Pediatrics II. Clinical studies are being conducted to investigate improved patient outcomes.
• Radboud University Nijmegen (DYNAMIC Consortium)flagshipStrategic or Co-development Partner · 1 September 2023The DYNAMIC consortium (seven Dutch institutions led by Radboud University Nijmegen) commissioned Neoscan to build the world's first 14 Tesla MRI magnet using HTS technology. The EUR 19M national lighthouse project is funded by Netherlands Research Council (NWO). The magnet will be installed at Radboud University and serve as an exceptional research platform for neuroscience, cognitive imaging, and molecular imaging research.
• Otto-von-Guericke-University MagdeburgcoreStrategic or Co-development PartnerNeoscan works closely with the Otto-von-Guericke-University and especially with the research campus STIMULATE. Professor Rose, director of STIMULATE, took the initiative to establish Neoscan in 2017. The university and research campus engage in joint research projects and provide access to qualified students, who Neoscan integrates even before graduation.
• MHH Hannover (Hannover Medical School)coreStrategic or Co-development PartnerCollaboration with MHH Radiology and Pediatric Pneumology teams on a pediatric lung imaging project funded by BMBF (Federal Ministry of Education and Research). Neoscan conducted usability testing and test sitting with the neo315 at MHH in November 2022.

Scale indicators4 records

Recent moves8 records

Expansion highlights6 records

Broad incumbents

• Siemens Healthineers: Siemens Healthineers is a dominant incumbent in MRI through its Magnetom product family, including pediatric-friendly wide-bore systems. While Neoscan targets a narrower point-of-care niche, Siemens competes in the broader pediatric MRI and component supply markets.
• GE HealthCare: GE HealthCare is a major incumbent MRI manufacturer via its SIGNA and OPTIMA product lines and is also active in neonatal imaging solutions. Comparable to Neoscan as a broad incumbent covering overlapping MRI and pediatric imaging use cases.
• Bruker BioSpin: Bruker BioSpin is a major manufacturer of high-field research and preclinical MRI/NMR systems. It is comparable as an incumbent in advanced research MRI, including ultra-high-field systems—a market that overlaps with Neoscan's 14T DYNAMIC project and research components.
• Canon Medical Systems: Canon Medical (formerly Toshiba Medical) is an incumbent MRI manufacturer with Vantage Galan and other 1.5T/3T systems. Comparable as a broad medical imaging incumbent whose installed base overlaps Neoscan's customer hospitals.
• Philips Healthcare: Philips is a large incumbent in MRI through its Ingenia and Ambition product lines, including pediatric configurations. Like Siemens and GE, it competes in adjacent pediatric MRI and is a potential partner or competitor for hospital-wide MRI deployments.

Emerging players

• MR Solutions: MR Solutions develops cryogen-free preclinical MRI systems using superconducting magnets. It is comparable to Neoscan as an emerging player focused on compact, cryogen-free magnet technology, primarily serving the research imaging segment.
• Magnetica: Magnetica develops superconducting magnet technology for medical and research MRI applications, including compact HTS-style systems. Comparable as an emerging player in specialized MRI magnet design targeting similar research and clinical markets as Neoscan's HTS magnet portfolio.
• Time Medical Systems: Time Medical develops dedicated neonatal and pediatric MRI systems targeting similar point-of-care NICU applications to Neoscan's neo315. It is comparable as an emerging player in the niche neonatal MRI category.

Direct peers

• Aspect Imaging: Aspect Imaging develops the Embrace NICU MRI system, a 1.0T dedicated neonatal MRI designed for installation inside the NICU. Both companies directly compete in the dedicated point-of-care neonatal/pediatric MRI segment with comparable clinical use cases.
• Hyperfine: Hyperfine is the closest direct competitor to Neoscan, producing the Swoop ultra-low-field portable MRI system for point-of-care bedside imaging in hospitals. Both companies target expanding MRI access outside traditional radiology suites, making them direct peers in the portable/point-of-care MRI category.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCKhtM4BUfjRHBpxAR4qO-4g
• LinkedInlinkedin.com/company/neoscan-solutions-gmbh
• Instagraminstagram.com/neoscansolutions
• Xx.com/Neoscan_mri

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Neoscan Solutions